La aspirina en la prevención primaria del cáncer colorrectal
Other Titles: 
Aspirin in the primary prevention of colorectal cancer
Keywords: 
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
Colorectal Neoplasms/prevention & control
Aspirin/therapeutic use
Issue Date: 
2012
Publisher: 
Gobierno de Navarra. Departamento de Salud
ISSN: 
1137-6627
Citation: 
Fernández Calderón M, Betés Ibáñez MT. Aspirina en la prevención primaria del cáncer colorrectal. An Sist Sanit Navar. 2012 May-Aug;35(2):261-7.
Abstract
Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with a reduction in the risk of developing adenomas and colorectal cancer. The available scientific evidence justifies the need for more studies that evaluate the protective effect of aspirin and other NSAIDs as a preventive measure against cancer of the colon; define the minimum efficient dosage; the age at which to begin treatment; the most convenient duration of the latter; and the sub-populations for which the benefits of chemoprophylaxis outweigh possible adverse effects.

Files in This Item:
Thumbnail
File: 
Anal Sist Sanit Navarra 15657-58482-1-.pdf
Description: 
Size: 
170,94 kB
Format: 
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.